Chiba Mitsuro, Sugawara Takeshi, Tozawa Haruhiko, Tsuda Hidehiko, Abe Toru, Tokairin Takuo, Ono Iwao, Ushiyama Eriko
Division of Gastroenterology, Nakadori General Hospital, 3-15, Misono-cho, Minami-dori, Akita 010-8577, Japan.
World J Gastroenterol. 2009 May 7;15(17):2166-9. doi: 10.3748/wjg.15.2166.
There have only been a few reports on lansoprazole-associated collagenous colitis. Colonic mucosa of collagenous colitis is known to be endoscopically normal. We present a case of collagenous colitis where the mucosa showed diffuse cloudiness mimicking ulcerative colitis. A 70-year-old woman developed watery diarrhea four to nine times a day. She had interstitial pneumonia at 67 and reflux esophagitis at 70 years. Lansoprazole 30 mg/d had been prescribed for reflux esophagitis for nearly 6 mo. Lansoprazole was withdrawn due to its possible side effect of diarrhea. Colonoscopy disclosed diffuse cloudiness of the mucosa which suggested ulcerative colitis. Consequently sulfasalazine 2 g/d was started. The patient's diarrhea dramatically disappeared on the following day. However, biopsy specimens showed subepithelial collagenous thickening and infiltration of inflammatory cells in the lamina propria, confirming the diagnosis of collagenous colitis. One month after sulfasalazine therapy was initiated, colonoscopic and histological abnormalities resolved completely. Five months later the diarrhea recurred. The findings on colonoscopy and histology were the same as before, confirming a diagnosis of collagenous colitis relapse. We found that the patient had begun to take lansoprazole again 3 mo ahead of the recent diarrhea. Withdrawal of lansoprazole promptly resolved the diarrhea. Endoscopic and histological abnormalities were also completely resolved, similar to the first episode. Retrospectively, the date of commencement of sulfasalazine and discontinuation of lansoprazole in the first episode was found to be the same. We conclude that this patient had lansoprazole-associated collagenous colitis.
关于兰索拉唑相关的胶原性结肠炎的报道仅有几例。已知胶原性结肠炎的结肠黏膜在内镜检查下是正常的。我们报告一例胶原性结肠炎病例,其黏膜呈现弥漫性浑浊,类似溃疡性结肠炎。一名70岁女性出现每天4至9次的水样腹泻。她67岁时患间质性肺炎,70岁时患反流性食管炎。因反流性食管炎已服用兰索拉唑30毫克/天近6个月。由于腹泻可能是其副作用,停用了兰索拉唑。结肠镜检查发现黏膜弥漫性浑浊,提示溃疡性结肠炎。因此开始使用柳氮磺胺吡啶2克/天。患者的腹泻在第二天显著消失。然而,活检标本显示上皮下胶原增厚以及固有层炎性细胞浸润,确诊为胶原性结肠炎。柳氮磺胺吡啶治疗开始1个月后,结肠镜和组织学异常完全消退。5个月后腹泻复发。结肠镜检查和组织学结果与之前相同,确诊为胶原性结肠炎复发。我们发现患者在最近一次腹泻前3个月又开始服用兰索拉唑。停用兰索拉唑后腹泻迅速缓解。内镜和组织学异常也完全消退,与首次发作时相似。回顾性分析发现,首次发作时开始使用柳氮磺胺吡啶和停用兰索拉唑的日期相同。我们得出结论,该患者患有兰索拉唑相关的胶原性结肠炎。